ATE365553T1 - Therapeutische zusammensetzungen welche einen überschuss eines amlodipin-enantiomers enthalten - Google Patents

Therapeutische zusammensetzungen welche einen überschuss eines amlodipin-enantiomers enthalten

Info

Publication number
ATE365553T1
ATE365553T1 AT01306940T AT01306940T ATE365553T1 AT E365553 T1 ATE365553 T1 AT E365553T1 AT 01306940 T AT01306940 T AT 01306940T AT 01306940 T AT01306940 T AT 01306940T AT E365553 T1 ATE365553 T1 AT E365553T1
Authority
AT
Austria
Prior art keywords
compositions containing
therapeutic compositions
containing excess
amlodipine
enantiomer
Prior art date
Application number
AT01306940T
Other languages
English (en)
Inventor
Suresh Babubhai Chahwala
Michael George Dodd
Michael John Humphrey
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=9898193&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE365553(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed filed Critical
Application granted granted Critical
Publication of ATE365553T1 publication Critical patent/ATE365553T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4422—1,4-Dihydropyridines, e.g. nifedipine, nicardipine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4866—Organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/02—Drugs for genital or sexual disorders; Contraceptives for disorders of the vagina
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Cardiology (AREA)
  • Reproductive Health (AREA)
  • Endocrinology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AT01306940T 2000-08-23 2001-08-15 Therapeutische zusammensetzungen welche einen überschuss eines amlodipin-enantiomers enthalten ATE365553T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0020842.1A GB0020842D0 (en) 2000-08-23 2000-08-23 Therapeutic compositions

Publications (1)

Publication Number Publication Date
ATE365553T1 true ATE365553T1 (de) 2007-07-15

Family

ID=9898193

Family Applications (1)

Application Number Title Priority Date Filing Date
AT01306940T ATE365553T1 (de) 2000-08-23 2001-08-15 Therapeutische zusammensetzungen welche einen überschuss eines amlodipin-enantiomers enthalten

Country Status (10)

Country Link
US (1) US6887886B2 (de)
EP (1) EP1181932B1 (de)
JP (1) JP2002114683A (de)
AT (1) ATE365553T1 (de)
BR (1) BR0103434A (de)
CA (1) CA2355493C (de)
DE (1) DE60129082T2 (de)
ES (1) ES2286082T3 (de)
GB (1) GB0020842D0 (de)
MX (1) MXPA01008528A (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7335380B2 (en) 2000-12-29 2008-02-26 Synthon Ip Inc. Amlodipine free base
AT5874U1 (de) * 2000-12-29 2003-01-27 Bioorg Bv Pharmazeutische zubereitungen enthaltend amlodipinmaleat
BE1014450A6 (nl) * 2000-12-29 2003-10-07 Bioorg Bv Werkwijze voor het maken van amlodipine, derivaten daarvan en voorlopers daarvoor.
WO2002053535A2 (en) * 2000-12-29 2002-07-11 Bioorganics B.V. Process for making amlodipine, derivatives thereof, and precursors therefor
DE60235101D1 (de) * 2001-07-06 2010-03-04 Lek Pharmaceuticals Verfahren zur herstellung hochreines amlodipinbenzolsulfonat
GB0120808D0 (en) * 2001-08-28 2001-10-17 Pfizer Ltd Crystalline material
WO2003032954A1 (en) * 2001-10-17 2003-04-24 Dr. Reddy's Laboratories Ltd. Stabilized pharmaceutical formulations containing amlodipine maleate
IL161448A0 (en) * 2001-10-24 2004-09-27 Sepracor Inc Method of resolving amlodipine racemate
NL1019882C2 (nl) * 2002-02-01 2003-08-04 Synthon Licensing Amlodipine vrije base.
BE1014922A3 (nl) * 2002-03-01 2004-06-01 Pfizer Ltd Amlodipine als vrije base.
EP1348697A1 (de) * 2002-03-28 2003-10-01 Council Of Scientific & Industrial Research Verfahren zur Herstellung von S(-)-amlodipine-L(+)-hemitartrate
KR100476636B1 (ko) * 2002-09-11 2005-03-17 한림제약(주) 엘-(+)-타르트레이트를 이용한 에스-(-)-암로디핀의 제조방법

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1013275A3 (de) * 1991-11-26 2001-01-10 Sepracor, Inc. Verfahren und Zusammensetzungen zur behandlung von Bluthochdruck, Angina und anderen Erkrankungen mit optisch Reinem(-) Amlodipin
US5389654A (en) * 1992-11-26 1995-02-14 Lek, Tovarna, Farmacevtskih In Kemicnih . . . 3-ethyl 5-methyl(±)2-[2-(N-tritylamino)ethoxymethyl]-4-(2-chlorophenyl)-1,4-dihydro-6-methyl-6-methyl-3,5-pyridinedicarboxylate
GB9317773D0 (en) * 1993-08-26 1993-10-13 Pfizer Ltd Therapeutic compound
GB9405833D0 (en) * 1994-03-24 1994-05-11 Pfizer Ltd Separation of the enantiomers of amlodipine
US6333342B1 (en) * 1998-11-04 2001-12-25 Isotechnika, Inc Methods of pharmacological treatment using S(−) amlodipine

Also Published As

Publication number Publication date
CA2355493A1 (en) 2002-02-23
DE60129082D1 (de) 2007-08-09
EP1181932A3 (de) 2003-12-10
US20020045648A1 (en) 2002-04-18
ES2286082T3 (es) 2007-12-01
GB0020842D0 (en) 2000-10-11
DE60129082T2 (de) 2008-02-28
CA2355493C (en) 2005-11-29
MXPA01008528A (es) 2005-02-17
BR0103434A (pt) 2002-03-26
US6887886B2 (en) 2005-05-03
JP2002114683A (ja) 2002-04-16
EP1181932B1 (de) 2007-06-27
EP1181932A2 (de) 2002-02-27

Similar Documents

Publication Publication Date Title
DE60129082D1 (de) Therapeutische Zusammensetzungen welche einen Überschuss eines Amlodipin-Enantiomers enthalten
ATE455092T1 (de) Substituierte tetracyclin-verbindungen zur behandlung von malaria
WO2003000200A3 (en) β-2'-OR 3'-HALONUCLEOSIDES
DE69018601D1 (de) Konzentrate von aktiven Verbindungen und Kombinationen von aktiven Verbindungen, ihre Verfahren zur Herstellung und Arzneimittel, die die Konzentrate oder die Kombinationen enthalten.
MY143466A (en) Inhibitors of tyrosine kinases
ATE406893T1 (de) Pharmazeutische zusammensetzung (kit) enthaltend dihydropyridinonverbindungen und eine verbindung mit immunmodulatorischer (oder antiinflammatorischer) wirkung und ihre verwendung
EA200000584A2 (ru) Твердые фармацевтические композиции с контролируемым высвобождением, получаемые тепловым формованием
WO2002098345A8 (fr) Utilisation d'un antioxydant pour le traitement et/ou la prevention des affections oculaires de surface
PT1205190E (pt) Composicoes medicinais estaveis para uso oral utilizando oxidos de ferro
TNSN05189A1 (en) Medium-chain length fatty acids, glycerides and analogues as stimulators of erythropoiesis
DK1350511T3 (da) Medicinsk sammensætning indeholdende aspirin
GEP20063926B (en) Pharmaceutical compositions of amlodipine and atorvastatin
DE60202958D1 (de) Stabiles polymorph von flibanserin, industrielles verfahren zu dessen herstellung und dessen verwendung zur herstellung von medikamenten
SE0101038D0 (sv) Novel compounds
DE60323510D1 (de) Implantat für den transport und die freigabe von pharmakologisch aktiven substanzen
DE60225262D1 (de) Granulatförmige zusammensetzungen und verfahren zu ihrer herstellung
MXPA03008801A (es) Aril oxima-piperazinas utiles como antagonistas de ccr5.
DK1147105T3 (da) Optisk aktivt pyridyl-4H-1,2,4-oxadiazinderivat og anvendelse af dette til behandling af karsygdomme
DE60115997D1 (de) 1,1- and 1,2-Disubstituierte Cyclopropane, Verfahren zu deren Herstellung und deren pharmazeutischen Zusammensetzungen
FI941911A0 (fi) Kondensoidut kinolyylidihydropyridiinit, menetelmä niiden valmistamiseksi ja niiden käyttö lääkeaineissa
DE69837334D1 (de) Heterozyclische verbindungen, ihr herstellungsverfahren und diese enthaltende pharmazeutische zusammensetzungen
YU35303A (sh) Preparati n-(1-metiletilaminokarbonil)-4-(3-metilfenil-amino)-3-piridinsulfonamida i cikličnih oligosaharida
DE60302951D1 (de) Pyroglutaminsäure-salz von Amlodipin
PL403800A1 (pl) Kompozycja farmaceutyczna
CY1110737T1 (el) Υποκατεστημενες ενωσεις 1,5-διαμινοπενταν-3-ολης

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties